These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34679355)

  • 1. Cluster Analysis of Categorical Variables of Parkinson's Disease Patients.
    Hendricks R; Khasawneh M
    Brain Sci; 2021 Sep; 11(10):. PubMed ID: 34679355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of Parkinson's Disease Cluster Analysis Research.
    Hendricks RM; Khasawneh MT
    Aging Dis; 2021 Oct; 12(7):1567-1586. PubMed ID: 34631208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's Disease Subtypes Identified from Cluster Analysis of Motor and Non-motor Symptoms.
    Mu J; Chaudhuri KR; Bielza C; de Pedro-Cuesta J; Larrañaga P; Martinez-Martin P
    Front Aging Neurosci; 2017; 9():301. PubMed ID: 28979203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.
    Dinov ID; Heavner B; Tang M; Glusman G; Chard K; Darcy M; Madduri R; Pa J; Spino C; Kesselman C; Foster I; Deutsch EW; Price ND; Van Horn JD; Ames J; Clark K; Hood L; Hampstead BM; Dauer W; Toga AW
    PLoS One; 2016; 11(8):e0157077. PubMed ID: 27494614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor subtype changes in early Parkinson's disease.
    Eisinger RS; Hess CW; Martinez-Ramirez D; Almeida L; Foote KD; Okun MS; Gunduz A
    Parkinsonism Relat Disord; 2017 Oct; 43():67-72. PubMed ID: 28754232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a prospective early motor progression cluster of Parkinson's disease: Data from the PPMI study.
    Vavougios GD; Doskas T; Kormas C; Krogfelt KA; Zarogiannis SG; Stefanis L
    J Neurol Sci; 2018 Apr; 387():103-108. PubMed ID: 29571843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling cognitive and neuropsychiatric heterogeneity in Parkinson's disease.
    van Balkom TD; Vriend C; Berendse HW; Foncke EM; van der Werf YD; van den Heuvel OA; Klein M
    Parkinsonism Relat Disord; 2016 Jul; 28():130-6. PubMed ID: 27215393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.
    Kang JH; Mollenhauer B; Coffey CS; Toledo JB; Weintraub D; Galasko DR; Irwin DJ; Van Deerlin V; Chen-Plotkin AS; Caspell-Garcia C; Waligórska T; Taylor P; Shah N; Pan S; Zero P; Frasier M; Marek K; Kieburtz K; Jennings D; Tanner CM; Simuni T; Singleton A; Toga AW; Chowdhury S; Trojanowski JQ; Shaw LM;
    Acta Neuropathol; 2016 Jun; 131(6):935-49. PubMed ID: 27021906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust identification of Parkinson's disease subtypes using radiomics and hybrid machine learning.
    Salmanpour MR; Shamsaei M; Saberi A; Hajianfar G; Soltanian-Zadeh H; Rahmim A
    Comput Biol Med; 2021 Feb; 129():104142. PubMed ID: 33260101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI).
    Nalls MA; Keller MF; Hernandez DG; Chen L; Stone DJ; Singleton AB;
    Mov Disord; 2016 Jan; 31(1):79-85. PubMed ID: 26268663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying and predicting Parkinson's disease subtypes through trajectory clustering via bipartite networks.
    Krishnagopal S; Coelln RV; Shulman LM; Girvan M
    PLoS One; 2020; 15(6):e0233296. PubMed ID: 32555729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporating spatial constraint in co-activation pattern analysis to explore the dynamics of resting-state networks: An application to Parkinson's disease.
    Zhuang X; Walsh RR; Sreenivasan K; Yang Z; Mishra V; Cordes D
    Neuroimage; 2018 May; 172():64-84. PubMed ID: 29355770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japan Parkinson's Progression Markers Initiative (J-PPMI).
    Mukai Y; Murata M
    Nihon Rinsho; 2017 Jan; 75(1):151-155. PubMed ID: 30566310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying subtypes of mild cognitive impairment in Parkinson's disease using cluster analysis.
    Pourzinal D; Yang JHJ; Byrne GJ; O'Sullivan JD; Mitchell L; McMahon KL; Copland DA; Dissanayaka NN
    J Neurol; 2020 Nov; 267(11):3213-3222. PubMed ID: 32535681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subspace Clustering of Categorical and Numerical Data With an Unknown Number of Clusters.
    Jia H; Cheung YM
    IEEE Trans Neural Netw Learn Syst; 2018 Aug; 29(8):3308-3325. PubMed ID: 28792907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.